GRAIL Details Plans for Early Cancer Detection Trials, Products
GRAIL management has confirmed that the company will be releasing a cell-free, DNA-based assay in Hong Kong this year to test for nasopharyngeal carcinoma. At the recent Precision Medicine World Conference, GRAIL also outlined their strategy for a circulating cell-free genome atlas trial. They plan to...